SRRK

Scholar Rock Holding Corp. is a biopharmaceutical company focused on developing innovative therapies for serious diseases. The company specializes in targeting growth factor signaling pathways, with lead programs in spinal muscular atrophy, obesity, and cancer. Its proprietary platform enables the discovery of monoclonal antibodies that modulate growth factor activity.